002773 Chengdu Kanghong Pharmaceutical Group
- 16.80
- -0.25-1.47%
Chengdu Kanghong Pharmaceutical Group News
Kanghong Pharmaceutical: An indicative announcement on the 2021 Stock Options Incentive Plan granting autonomous exercise rights for part of the third exercise period for the first time
Kanghong Pharmaceutical: An indicative announcement on the 2021 Stock Options Incentive Plan to reserve the right to exercise independently during part of the second exercise period
Kanghong Pharmaceutical: Announcement on the completion of cancellation of some stock options under the 2021 Stock Option Incentive Plan
Chengdu Kanghong Pharmaceutical Group: The list of eligible options incentive recipients for the first partial exercise period of the 2021 stock options incentive plan and the reserved grants for the second exercise period
Chengdu Kanghong Pharmaceutical Group: Peking Tongshang (Shenzhen) Law Firm's legal opinion on the cancellation of part of the stock options and the first grant of part of the stock options in the stock option incentive plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd. in 2021, the achievement of the exercise conditions for the third exercise period, and the reserved grant of part of the stock options for the second exercise period.
Chengdu Kanghong Pharmaceutical Group: Announcement about the achievement of the exercise conditions of the first exercise period for the 2021 stock options incentive plan and the reservation of the second exercise period.
Chengdu Kanghong Pharmaceutical Group: Announcement on the cancellation of a portion of stock options in the 2021 stock option incentive plan.
Chengdu Kanghong Pharmaceutical Group: Announcement on adjusting the exercise price of the Company's 2022 Stock Value-added Rights Incentive Plan
Chengdu Kanghong Pharmaceutical Group: Announcement on adjusting the exercise price of the Company's 2023 Stock Value-added Rights Incentive Plan
Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the adjustment of the exercise price of the 2021 stock option incentive plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group: Announcement on adjusting the exercise price of the company's 2021 stock option incentive plan
Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the adjustment of the exercise price of Chengdu Kanghong Pharmaceutical Group Co., Ltd. 2022 Stock Value-added Incentive Plan
Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the adjustment of the exercise price of the 2023 Stock Value-added Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group: Notice on the implementation of equity allocation for the year 2023
Kanghong Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
Kanghong Pharmaceutical: Announcement on granting stock appreciation rights to incentive recipients
Kanghong Pharmaceutical: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the granting of stock value-added rights in the 2023 Stock Value-added Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Kanghong Pharmaceutical: Self-inspection report on insider information on the 2023 Stock Value-added Rights Incentive Plan and the incentive target\'s stock trading situation
Kanghong Pharmaceutical: Supervisory Committee\'s Public Explanation and Audit Opinions on the List of Incentives for Stock Value-Added Rights in 2023
Kanghong Pharmaceutical: Summary of the 2023 Stock Value-Added Rights Incentive Plan (Draft)
Analysis
Price Target
No Data
No Data